Global Eosinophilic Esophagitis Drug Market Survey and Trend Research 2018

June 2018 | 76 pages | ID: G85ACE639C3EN
99Strategy

Abstracts

SUMMARY

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (AstraZeneca, GSK, Bayer, Adare Pharmaceuticals, Dr. Falk Pharma, Dr. Falk Pharma, Quorum Innovations, Shire, Calypso, Celgene, Regeneron etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Eosinophilic Esophagitis Drug Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 EOSINOPHILIC ESOPHAGITIS DRUG MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 Key Companies List
4.1 AstraZeneca (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 GSK (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Bayer (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Adare Pharmaceuticals (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Dr. Falk Pharma (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Dr. Falk Pharma (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Quorum Innovations (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Shire (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Calypso (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Celgene (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Regeneron (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Eosinophilic Esophagitis Drug Market 2012-2017, by Type, in USD Million
Table Global Eosinophilic Esophagitis Drug Market 2012-2017, by Type, in Volume
Table Global Eosinophilic Esophagitis Drug Market Forecast 2018-2023, by Type, in USD Million
Table Global Eosinophilic Esophagitis Drug Market Forecast 2018-2023, by Type, in Volume
Table AstraZeneca Overview List
Table Eosinophilic Esophagitis Drug Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Eosinophilic Esophagitis Drug Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Eosinophilic Esophagitis Drug Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Adare Pharmaceuticals Overview List
Table Eosinophilic Esophagitis Drug Business Operation of Adare Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Falk Pharma Overview List
Table Eosinophilic Esophagitis Drug Business Operation of Dr. Falk Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Falk Pharma Overview List
Table Eosinophilic Esophagitis Drug Business Operation of Dr. Falk Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Quorum Innovations Overview List
Table Eosinophilic Esophagitis Drug Business Operation of Quorum Innovations (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shire Overview List
Table Eosinophilic Esophagitis Drug Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Calypso Overview List
Table Eosinophilic Esophagitis Drug Business Operation of Calypso (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Overview List
Table Eosinophilic Esophagitis Drug Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Regeneron Overview List
Table Eosinophilic Esophagitis Drug Business Operation of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Eosinophilic Esophagitis Drug Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Eosinophilic Esophagitis Drug Sales Revenue Share, by Companies, in USD Million
Table Global Eosinophilic Esophagitis Drug Sales Volume 2012-2017, by Companies, in Volume
Table Global Eosinophilic Esophagitis Drug Sales Revenue Share, by Companies in 2017, in Volume
Table Eosinophilic Esophagitis Drug Demand 2012-2017, by Application, in USD Million
Table Eosinophilic Esophagitis Drug Demand 2012-2017, by Application, in Volume
Table Eosinophilic Esophagitis Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Eosinophilic Esophagitis Drug Demand Forecast 2018-2023, by Application, in Volume
Table Global Eosinophilic Esophagitis Drug Market 2012-2017, by Region, in USD Million
Table Global Eosinophilic Esophagitis Drug Market 2012-2017, by Region, in Volume
Table Eosinophilic Esophagitis Drug Market Forecast 2018-2023, by Region, in USD Million
Table Eosinophilic Esophagitis Drug Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Eosinophilic Esophagitis Drug Industry Chain Structure
Figure Global Eosinophilic Esophagitis Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Eosinophilic Esophagitis Drug Market Growth 2012-2017, by Type, in Volume
Figure Global Eosinophilic Esophagitis Drug Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Eosinophilic Esophagitis Drug Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region